Publication | Open Access
A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001)
24
Citations
16
References
2022
Year
The trial was registered under Clinical Trial Registry of India (no.CTRI/2018/02/011905).
| Year | Citations | |
|---|---|---|
Page 1
Page 1